Company Profile for Cancer Genetics, Inc.Business Editors --(BUSINESS WIRE) CGI develops and markets new genetically derived probes for the diagnostic/prognostic 1. Of, relating to, or useful in prognosis. 2. Of or relating to prediction; predictive. n. evaluation of cancer and intends to serve as an
international resource for the genetics evaluation of cancer patients
and families. The company's efforts are organized on three
platforms: (1) novel nucleic acid probes based on new and innovatibe
FISH probe technology, (2) clinical cancer cytogenetic cytogenetic /cy·to·ge·net·ic/ (-je-net´ik) 1. A sign or symptom indicating the future course of a disease. 2. A sign of a future happening; a portent. 1. pertaining to chromosomes. 2. pertaining to cytogenetics. testing, and (3)
clinical trials research performed through state-of-the-art genetic
analysis.
Company: Cancer Genetics, Inc.
Headquarters Address: 321 Fortune Blvd.
Milford, MA 01757
Main Telephone: (508) 458-1040
Website: www.cancergenetics.com
Type of Organization: Private
Industry: Health: Biotechnology
Key Executives: Vice President Marketing & Sales: Peter
Hartmayer
Investor Relations
Contact: Peter Hartmayer
Phone: (508) 458-1040 x114
Email: peter@cancergenetics.com
Customer Service
Contact: Sumana Devata
Phone: (508) 458-1040 x113
Email: suma@cancergenetics.com
|
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion